Afghanistan

in page functions
[French]
Afghanistan
Total population (2016) 33,369,916
Birth cohort (2016) 1,081,810
Surviving Infants (surviving to 1 year per year, 2016) 1,010,762
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 66/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 91/1000
World Bank Index, IDA (2012) 2.63
Co-financing status (2016) Initial self-financing
No. of districts/territories (2015) 329

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Afghanistan

Type of support

Approvals

2001-2021 (US$)
(20 Dec 2016)

Commitments

2001-2021 (US$)
(20 Dec 2016)

Disbursements

2000-2016 (US$)
(20 Dec 2016)

% Disbursed

(20 Dec 2016)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $275,739,761 $341,934,335 $245,134,291
Civil Society Organisation support (CSO) $3,576,400 $3,576,400 $3,892,300 109%
Health system strengthening (HSS 1) $34,100,000 $34,100,000 $34,100,000 100%
Health system strengthening (HSS 2) $17,401,585 $18,214,478 $16,682,780 96%
Health system strengthening (HSS 3) $21,133,677 $39,898,858 $6,286,842 30%
Immunisation services support (ISS) $14,025,300 $14,025,300 $14,025,300 100%
Injection Safety Devices (NVS) $617,500 $1,636,500
Injection safety support (INS) $1,676,500 $1,676,500 $1,676,500 100%
IPV (NVS) $3,347,500 $3,347,500 $1,840,855 55%
Measles SIA (NVS) $2,163,903 $2,163,903 $2,163,903 100%
Measles SIA - Operational costs (OPC) $3,574,000 $3,574,000 $3,574,000 100%
Penta (NVS) $74,429,002 $86,585,502 $65,639,904 88%
Pneumo (NVS) $87,278,761 $120,719,761 $82,836,274 95%
Tetra DTP-HepB (NVS) $9,903,633 $9,903,633 $9,903,633 100%
Vaccine Introduction Grant (VIG) $2,512,000 $2,512,000 $2,512,000 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Afghanistan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2015)

Grade of confidence


N/A
DTP3 - Official country estimates (2015) 98%
M:F sex ratio at birth (2016) 1.06
Household survey: DTP3 coverage for male (2010) 41.60%
Household survey: DTP3 coverage for female (2010) 38.90%
Household survey: Last DTP3 survey (2010) 40%
% districts achieving > 80% DTP3 coverage (2015) 63%
% districts achieving < 50% DTP3 coverage (2015) 10%
MCV WHO/UNICEF estimates (2015) 68%

Breakdown of support

Non-vaccine support Vaccine support
34% 66%
$82,749,722 $162,384,566

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Afghanistan

24 October 2016

World Polio Day a

Polio portraits: voices from the frontline of eradication

Today marks World Polio Day, when the global community celebrates the immense progress and considers the work ahead to ensure no child suffers from polio ever again.

02 November 2015

Afghanistan airport

Afghanistan ensures safe passage of life-saving vaccines

Afghan health ministry shows commitment to immunisation by opening critical storage facility at central airport.

30 September 2015

Afghanistan IPV

New polio vaccine introduced to accelerate polio eradication in Afghanistan

More than one million children to benefit from the new polio vaccine

close icon

modal window here